Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12

In this study we describe the generation and characterization of interspecies somatic cell hybrids between human activated mature T cells and mouse BW5147 thymoma cells. A preferential segregation of human chromosomes was observed in the hybrids. Phenotypic analysis of two hybrids and their clones demonstrated coexpression of CD4 and CD69 antigens in the same cells. Segregation analysis of an informative family of hybrids followed by molecular and karyotype studies clearly demonstrated that the locus encoding CD69 antigen mapped to human chromosome 12. Although the expression of CD69 antigen is an early event after T-lymphocyte activation and rapidly declines in absence of exogenous stimuli, in the hybrids described in this study the expression was constitutive, similarly to what was previously found in early thymocyte precursors and mature thymocytes. In this respect it was important to note that the behavior of the hybrids in culture strongly suggested a dominant influence of the thymus-derived mouse tumor cell genome in controlling the constitutive expression of human CD69. These hybrids may thus provide a system to study the genetic and molecular mechanisms controlling the expression and function of this activation antigen.

[1]  G. Crabtree,et al.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. , 1990, Annual review of immunology.

[2]  R. Testi,et al.  Constitutive expression of a phosphorylated activation antigen (Leu 23) by CD3bright human thymocytes. , 1988, Journal of Immunology.

[3]  R. Testi,et al.  CD69 is expressed on platelets and mediates platelet activation and aggregation , 1990, The Journal of experimental medicine.

[4]  L. Lanier,et al.  Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen , 1988, The Journal of experimental medicine.

[5]  J. Redondo,et al.  Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase C , 1989, European journal of immunology.

[6]  M. Capra,et al.  CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. , 1991, Journal of immunology.

[7]  J. Coligan,et al.  Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. , 1988, Journal of immunology.

[8]  A. Rubartelli,et al.  MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors , 1989, European journal of immunology.

[9]  S. Nakamura,et al.  Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1 , 1989, The Journal of experimental medicine.

[10]  F. Sánchez‐Madrid,et al.  Structure‐function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69 , 1991, European journal of immunology.

[11]  E. Shevach,et al.  Very Early (VEA) and Very Late (VLA) Activation Antigens have Distinct Functions in T Lymphocyte Activation , 1989, Immunological reviews.

[12]  F. Cozzolino,et al.  Functional characterization of an antigen involved in an early step of T-cell activation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Fu,et al.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o- tetradecanoyl phorbol-13-acetate, mitogens, and antigens , 1986, The Journal of experimental medicine.

[14]  R. Testi,et al.  T cell activation via Leu-23 (CD69). , 1989, Journal of immunology.

[15]  R. Testi,et al.  Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. , 1989, Journal of immunology.

[16]  T. Pozzan,et al.  Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes. , 1991, Molecular immunology.

[17]  F. Sánchez‐Madrid,et al.  Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes , 1988, The Journal of experimental medicine.

[18]  S. Nakamura,et al.  The 28-kDa/32-kDa activation antigen EA 1. Further characterization and signal requirements for its expression. , 1988, Journal of immunology.

[19]  K. Sugamura,et al.  Activation of natural killer cells via the p75 interleukin 2 receptor , 1989, The Journal of experimental medicine.

[20]  J. Guardiola,et al.  Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes , 1985, The Journal of experimental medicine.

[21]  S. Nakamura,et al.  Expression of early activation antigen (CD69) during human thymic development , 1990, Clinical and experimental immunology.

[22]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .